CIK 0001023024
- Large accelerated filer
ANI PHARMACEUTICALS INC
Sign in to watch- Ticker
- ANIP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 582301143
- Phone
- +1 609-759-1810
- Business address
- 104 CARNEGIE CENTER DRIVE SUITE 300, PRINCETON, NJ, 08540
- Former names
- BIOSANTE PHARMACEUTICALS INC, BEN ABRAHAM TECHNOLOGIES INC
- 4 Grant or award Director acquired 7,421 shares (grant or award)
- 4 Grant or award Director acquired 7,421 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Interim President and CEO acquired 7,050 shares (grant or award)
- 4 Grant or award Director acquired 7,119 shares (grant or award)
- 4 Grant or award Director acquired 7,119 shares (grant or award)
- 4 Grant or award Director acquired 7,119 shares (grant or award)
- 4 Grant or award Director acquired 9,255 shares (grant or award)
- 4 Grant or award Vice President and CFO acquired 39,767 shares (grant or award)
- 4 Grant or award SVP - New Bus Dev & Spec Sales acquired 39,767 shares (grant or award)
- 4 Grant or award SVP Ops & Prod Dev acquired 24,548 shares (grant or award)
- 4 Shares withheld for taxes SVP - New Bus Dev & Spec Sales gave up 1,062 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 5,397 shares (to pay taxes)
- 4 Shares withheld for taxes SVP Ops & Prod Dev gave up 481 shares (to pay taxes)
- 4 Shares withheld for taxes Vice President and CFO gave up 612 shares (to pay taxes)
- 4 Shares withheld for taxes SVP - New Bus Dev & Spec Sales gave up 1,589 shares (to pay taxes)
- 4 Shares withheld for taxes Vice President and CFO gave up 1,460 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 6,883 shares (to pay taxes)
- 4 Open-market buy Director bought 5,000 shares at an average $45.10 ($225,510)
Page 19 of 42 · 835 filings